No, Enterococcus faecalis is NOT the same as bacteremia
Enterococcus faecalis is a bacterial species (a type of gram-positive bacteria), while bacteremia is a clinical condition defined by the presence of bacteria in the bloodstream. E. faecalis can cause bacteremia, but they are fundamentally different concepts—one is a microorganism, the other is a disease state.
Understanding the Distinction
Enterococcus faecalis is:
- A specific bacterial pathogen that normally inhabits the gastrointestinal tract
- The most common enterococcal species causing invasive infections (accounting for approximately 90% of enterococcal bacteremia cases) 1, 2
- A gram-positive organism that can cause various infections including urinary tract infections, intra-abdominal infections, wound infections, and bloodstream infections
Bacteremia is:
- A clinical syndrome characterized by the presence of viable bacteria in the bloodstream
- Detected through positive blood cultures
- Can be caused by many different bacterial species, not just E. faecalis 3
Clinical Context: E. faecalis Bacteremia
When E. faecalis enters the bloodstream, it causes E. faecalis bacteremia, which is a specific type of bloodstream infection with important clinical implications:
Epidemiology and Risk Factors
- Accounts for approximately 5.2% of all bloodstream infections globally 3
- Predominantly hospital-acquired (83.2% nosocomial origin) 4
- Associated with invasive procedures (85.3% of cases) 4
- Common sources include urinary tract (36.4%), vascular catheters (15.1%), intra-abdominal infections, and unknown origins (48.5%) 5
Key Clinical Concerns
The major complication requiring vigilance is infective endocarditis (IE). Studies show:
- 25% of community-acquired E. faecalis bacteremia cases have IE 6
- Recent data suggests up to 26% prevalence when transesophageal echocardiography is routinely performed 7
- 16.7% overall rate of IE development in E. faecalis bacteremia 7
Mortality and Prognosis
- Overall mortality: 21.4-23.9% 4, 6
- Only 9.9% directly attributable to bacteremia itself 4
- Poor prognostic factors include: inappropriate antibiotic treatment, mechanical ventilation, polymicrobial bacteremia, and underlying oncological disease 5, 4
Treatment Principles
Ampicillin remains the drug of choice for susceptible E. faecalis 1, 8, 4:
- Ampicillin or penicillin G combined with gentamicin for 4-6 weeks for native valve IE 9, 1
- Vancomycin reserved for β-lactam intolerance or ampicillin resistance 9, 8
- For aminoglycoside-resistant strains, ampicillin-ceftriaxone combination is reasonable 9
- Duration: 7-14 days for uncomplicated catheter-related bacteremia; 4-6 weeks for IE 8
Critical Diagnostic Steps
All patients with E. faecalis bacteremia require risk stratification for endocarditis 8:
- Transthoracic echocardiography for initial evaluation
- Transesophageal echocardiography indicated for: new murmur, embolic phenomena, persistent bacteremia >72 hours, prosthetic valves, or community-acquired infection 8, 6
- The low rate of echocardiography use (only 37.9% in some cohorts) likely results in missed IE diagnoses 7
Common Pitfall
The most significant clinical error is conflating the organism with the disease state. When discussing patient care, precision matters: a patient doesn't have "Enterococcus faecalis"—they have "bacteremia caused by Enterococcus faecalis" or "E. faecalis bloodstream infection." This distinction ensures appropriate diagnostic workup (blood cultures, echocardiography) and targeted antimicrobial therapy rather than treating the organism in isolation.